G. Lazaro

A systematic molecular and pharmacologic evaluation of AKT inhibitors reveals new insight into their biological activity

I. Vivanco, F. Raynaud, B. Schwartz, 2020, British Journal of Cancer.

Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab response.

Chris Smith, R. Nicholson, S. Hiscox, 2013, Endocrine-related cancer.

Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma

Charles Y. Lin, J. Bradner, N. Gray, 2020, The Journal of clinical investigation.

Inhibitors in AKTion: ATP-competitive vs allosteric

I. Vivanco, E. Kostaras, G. Lazaro, 2020, Biochemical Society transactions.

Focal Adhesion Kinase (FAK) as a novel therapeutic target in HER2+ breast cancer

G. Lazaro, 2015 .

Nestin regulates prostate cancer cell invasion by influencing the localisation and functions of FAK and integrins

Joanna W Pylvänäinen, J. Eriksson, G. Lazaro, 2014, Journal of Cell Science.

A systematic molecular and pharmacologic evaluation of AKT inhibitors reveals new insight into their biological activity

I. Vivanco, F. Raynaud, B. Schwartz, 2020, British Journal of Cancer.

Computer-aided identification of novel anticancer compounds with a possible dual HER1/HER2 inhibition mechanism.

A. Brancale, S. Hiscox, K. Amin, 2015, Bioorganic & medicinal chemistry letters.